| Pregnanediol-3-alpha-Glucuronide
|
This assay was originally developed for the World Health Organization as a
non-invasive monitor of ovarian function. It has been widely used in
clinical trials and in the assessment of natural family planning methods.
|
 |
| Method
|
Urine samples are diluted in buffer and the Pregnanediol-3a-Glucuronide
concentration measured by EIA (enzyme labelled immunoassay with magnetic
second antibody separation). All samples, standards and quality control
specimens are assayed in duplicate.
|
 |
| Quality Control
|
Assays are controlled through the use of at least 2 Internal Quality Control
samples in every run. In addition the performance of every run is closely
monitored for various parameters including imprecision, antibody binding of
tracer, non-specific binding and reproducibility of the standard curve.
- Standard Curve: The range of the standard curve is 0 to 80 nmol/L.
- Precision: The between-run precision of the assay is generally less than 10% CV.
- Sensitivity: The sensitivity of the assay is approximately 1 nmol/L
(defined as 2 standard deviations in the measurement of zero dose ).
|
 |
| Specificity
|
The cross-reactions of the Pregnanediol-3a-Glucuronide antibody (estimated
as the relative potency causing a 50% displacement of zero binding) are
shown below:
| Substance | % Cross Reaction | | Pregnanediol-3-a-Glucuronide | 100 | | Pregnanediol | 4.6 |
|
For more information and prices please
contact us.
|